Medikit Co.,Ltd., together with its subsidiaries, develops, manufactures, and sells medical devices related to blood vessels and blood in Japan and internationally. The company offers IV catheters, such as Supercath 5 and Supercath Ztu-V; hemodialysis products, including Supercath PRO, Supercath NEO, and Supercath Clampcath; and intervention products comprising Supersheath sheath introducers and Mongoose angiography catheters. It also provides indwelling needles for artificial dialysis; and needles for blood transfusions and intravenous fluid. Medikit Co.,Ltd. was founded in 1973 and is headquartered in Bunkyo, Japan.
Frequently asked questions
What sector does Medikit Co Ltd (7749) operate in?
Medikit Co Ltd belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Medikit Co Ltd (7749) current stock price?
As of the latest data, Medikit Co Ltd stock price is ¥2,860, with a previous close of ¥2,878. Medikit Co Ltd lost -¥18 in the last trading session, representing a -0.63% loss.
What is Medikit Co Ltd (7749) current market capitalization?
Medikit Co Ltd market cap is approximately 41.41 billion.
What is Medikit Co Ltd (7749) Earnings Per Share (EPS)?
The trailing EPS is ¥206.
What is Medikit Co Ltd (7749) Price-to-Earnings (P/E) ratio?
Medikit Co Ltd current P/E ratio is 13.86.
What is Medikit Co Ltd (7749) EBITDA?
Medikit Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.80 billion.
Does Medikit Co Ltd (7749) pay dividends?
Yes. Medikit Co Ltd pays semiannual dividends with an annualized yield of 3.5% and an estimated annual payout of ¥100 per share.
When is the next ex-dividend date for Medikit Co Ltd (7749)?
The next ex-dividend date is scheduled for September 30, 2026.
What is Medikit Co Ltd (7749) beta (volatility) score?
Medikit Co Ltd has a beta of 0.100, indicating lower volatility than the overall market.
